Office Number: 203-815-5782

Email:

MARKET OPPORTUNITIES

Hepatitis B Virus Global Statistics

• 2 Billion people have been infected (1 out of 3 people).

• 240 Million people are chronically infected.

• 10-30 Million will become infected each year.

• Chronic HBV infection is the major cause of hepatocellular carcinoma

• Over 500,000 people die each year from HBV and its complications

 

Global Market for HBV Drugs

• HBV anti-viral drugs: $3.1 Billion will hit $4.4 Billion (2019)

• Drugs do not cure chronic disease

• No FDA approved and marketed therapeutic vaccine

 

 Global Market for Vaccines

• Human and animal vaccines: $25 Billion and projected to grow to $100 Billion (2024)

• Hepatitis B virus vaccines: $1.0 Billion and projected to grow to 1.8 Billion (2018)

 

 

FINANCING-TO-DATE

 

The Company has secured more than $3 million to fund its vaccine development and operations. Most of the financing has come from Connecticut Innovations (http://www.ctinnovations.com), followed by G. P. Healthcare (www.gerpanghealthcare.com), Shandong Province, China; and from non-dilutive funding sources such as grants and awards.

INDEX

Market Opportunities

Home

Technology

Investors

CaroGen Corporation

 

Cell & Genome Sciences Building R2802

 

400 Farmington Ave

 

Farmington, CT 06032

 

Tel: 203-815-5782

Copyright 2018 CaroGen Corporation

About Us